Rosen Hugh
SEC insider (Form 3/4/5 filer). CIK 0001672470. Director at Regulus Therapeutics Inc. (RGLS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2025. Located in SAN DIEGO, CA.
Companies Rosen Hugh has filed insider reports for
- Regulus Therapeutics Inc. (RGLS): Director
Rosen Hugh
CIK: 0001672470
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RGLS
Regulus Therapeutics Inc.
Director